DrugPatentWatch Database Preview
GOCOVRI Drug Profile
or, see our see our flat-rate plans
Which patents cover Gocovri, and when can generic versions of Gocovri launch?
This drug has eighteen patent family members in seven countries.
The generic ingredient in GOCOVRI is amantadine hydrochloride. There are seven drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
Summary for GOCOVRI
| International Patents: | 18 |
| US Patents: | 13 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 119 |
| Patent Applications: | 1,432 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GOCOVRI |
| DailyMed Link: | GOCOVRI at DailyMed |
Medical Subject Heading (MeSH) Categories for GOCOVRI
US Patents and Regulatory Information for GOCOVRI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-002 | Aug 24, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-002 | Aug 24, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-002 | Aug 24, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
Paragraph IV (Patent) Challenges for GOCOVRI
| Drugname | Dosage | Strength | RLD | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 137 mg | ➤ Subscribe | 2018-01-16 |
Non-Orange Book US Patents for GOCOVRI
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,987,333 | Composition and method for treating neurological disease | ➤ Try a Free Trial |
| 9,072,697 | Composition and method for treating neurological disease | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
or, see our see our flat-rate plans
International Patents for GOCOVRI
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 106389381 | ➤ Try a Free Trial |
| European Patent Office | 2623099 | ➤ Try a Free Trial |
| Mexico | 2012006320 | ➤ Try a Free Trial |
| Canada | 2588296 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
